Tirzepatide vs Semaglutide: How the Two Weight-Loss Drugs Compare

You are weighing two of the most talked-about weight-loss medications, and the names alone are a mouthful, tirzepatide and semaglutide. You have probably heard that both can lead to real weight loss, but you want to know which one is actually better, and whether the difference is big enough to matter. The good news is that there is now direct, head-to-head research to help answer that.

Here is the short version: both drugs work, but in the first trial that compared them face to face, tirzepatide produced more weight loss than semaglutide. The fuller picture, including why they differ and how they feel day to day, is worth understanding before you and a clinician decide which fits you.

What are tirzepatide and semaglutide?

Tirzepatide and semaglutide are injectable prescription medications used for chronic weight management and, in other formulations, type 2 diabetes. They belong to a class of drugs that mimic gut hormones your body naturally releases after eating, which help curb appetite, slow stomach emptying, and improve how your body handles blood sugar.

The key difference is in how many hormone pathways each drug targets. Semaglutide is a single GLP-1 receptor agonist, meaning it acts on one receptor (GLP-1). Tirzepatide is a dual agonist: it acts on the GLP-1 receptor and also on the GIP (glucose-dependent insulinotropic polypeptide) receptor. That added GIP activity is widely credited for tirzepatide's greater effect on weight.

Tirzepatide vs semaglutide: which causes more weight loss?

For weight loss, the current evidence favors tirzepatide. The clearest data come from SURMOUNT-5, the first head-to-head randomized, double-blind trial directly comparing the two drugs, published in the New England Journal of Medicine in 2025. It enrolled 751 adults who had obesity but not type 2 diabetes and followed them for 72 weeks on the maximum tolerated weekly dose of each medication.

The results favored tirzepatide on the main measure and several others:

• Average weight loss at 72 weeks was 20.2% with tirzepatide (up to 15 mg) versus 13.7% with semaglutide (2.4 mg), a 6.5 percentage-point absolute difference, P<0.001.
• That works out to roughly 47% greater relative weight loss with tirzepatide.
• 31.6% of people on tirzepatide lost at least 25% of their body weight, compared with 16.1% on semaglutide.
• Waist circumference fell 18.4 cm with tirzepatide versus 13.0 cm with semaglutide.
• A 2025 systematic review and meta-analysis pooling seven studies and 28,980 participants reached the same conclusion: tirzepatide led to greater weight loss.

How do they differ in side effects?

Both medications share a similar side-effect profile, and the most common complaints are gastrointestinal: nausea, diarrhea, constipation, and vomiting, especially in the early weeks and when the dose is increased.

Interestingly, in the SURMOUNT-5 trial, tirzepatide was associated with fewer gastrointestinal side effects than semaglutide. Researchers suspect this may be related to GIP's role in modulating nausea and vomiting pathways. Even so, every person reacts differently, and tolerability is one of the main reasons doses are raised slowly under a clinician's guidance.

Beyond the scale: other health effects

Weight is not the only thing these medications influence. In SURMOUNT-5, tirzepatide also showed greater improvements across several cardiometabolic measures compared with semaglutide, including systolic and diastolic blood pressure, HbA1c (a marker of blood sugar over time), fasting insulin, triglycerides, and HDL cholesterol.

This matters because for many people the goal is not just a smaller number on the scale but lower risk from conditions tied to excess weight. That said, both drugs have been shown to improve these markers; the trial found tirzepatide's improvements were larger on average.

Which one is right for you?

On weight loss alone, the head-to-head data point toward tirzepatide. But better on average does not automatically mean better for you. The right choice depends on your medical history, other conditions, how you tolerate each medication, insurance coverage, cost, and availability, all of which a prescribing clinician weighs with you.

These are prescription medications that require medical supervision. They are not appropriate for everyone, and they carry warnings and contraindications that a clinician must review before starting. Never adjust a dose, combine medications, or use a product obtained without a prescription on your own.

When to talk to a doctor

If you are considering either medication, the safest next step is a conversation with a licensed clinician who can review your full history and lab work and decide whether one of these drugs fits your situation.

Seek urgent medical care if, while taking either medication, you have severe or persistent abdominal pain (which can signal pancreatitis or gallbladder problems), signs of an allergic reaction, persistent vomiting with dehydration, or symptoms of very low blood sugar such as confusion, shakiness, or fainting, particularly if you also take other diabetes medications.